menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Treating Steroid-Refractory Chronic GVHD: How to Transition to Second-Line Therapy

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Related
Comments
  • Overview

    Did you know that only about a third of patients with chronic graft versus host disease (GVHD) will have a durable response to steroids? Learn how you can better manage patients with steroid-refractory chronic GVHD with this expert panel featuring Dr. Ned Waller, Director of the Regenerative Medicine Program at the Winship Cancer Institute of Emory University, and Dr. George Chen, Associate Professor of Stem Cell Transplantation at the MD Anderson Cancer Center in Houston.

Facebook Comments

Recommended
Details
Presenters
Related
Comments
  • Overview

    Did you know that only about a third of patients with chronic graft versus host disease (GVHD) will have a durable response to steroids? Learn how you can better manage patients with steroid-refractory chronic GVHD with this expert panel featuring Dr. Ned Waller, Director of the Regenerative Medicine Program at the Winship Cancer Institute of Emory University, and Dr. George Chen, Associate Professor of Stem Cell Transplantation at the MD Anderson Cancer Center in Houston.

Facebook Comments

Schedule15 Apr 2024